Background Patients from ethnic minority groups are disproportionately affected by
Coronavirus disease (COVID-19). We performed a systematic review and meta-analysis to …

Background The relationship between ethnicity and COVID-19 is uncertain. We performed a
systematic review to assess whether ethnicity has been reported in patients with COVID-19 …

On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B. 1.1.
529 was announced, containing far more mutations in Spike (S) than previously reported …

Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection …

Background COVID-19 has exacerbated existing ethnic inequalities in health. Little is known
about whether inequalities in severe disease and deaths, observed globally among …

As the coronavirus disease 2019 (COVID-19) pandemic continues advancing globally,
reporting of clinical outcomes and risk factors for intensive care unit admission and mortality …

Adoptive cell transfers have emerged as a disruptive approach to treat disease in a manner
that is more specific than using small-molecule drugs; however, unlike traditional drugs …

Background Some high-income countries have deployed fourth doses of COVID-19
vaccines, but the clinical need, effectiveness, timing, and dose of a fourth dose remain …

Nanoparticulate drug delivery systems are one of the most widely investigated approaches
for developing novel therapies for a variety of diseases. However, rapid clearance and poor …

Drug delivery by nanocarriers (NCs) has long been stymied by dominant liver uptake and
limited target organ deposition, even when NCs are targeted using affinity moieties. Here we …